These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 19383643)

  • 1. Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients.
    Bernal F; Elias B; Hartung HP; Kieseier BC
    Mult Scler; 2009 Jun; 15(6):721-7. PubMed ID: 19383643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.
    Gilli F; Bertolotto A; Sala A; Hoffmann F; Capobianco M; Malucchi S; Glass T; Kappos L; Lindberg RL; Leppert D
    Brain; 2004 Feb; 127(Pt 2):259-68. PubMed ID: 14607790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
    Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
    Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis.
    Comabella M; Río J; Espejo C; Ruiz de Villa M; Al-Zayat H; Nos C; Deisenhammer F; Baranzini SE; Nonell L; López C; Julià E; Oksenberg JR; Montalban X
    Clin Immunol; 2009 Feb; 130(2):145-50. PubMed ID: 18945642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results.
    Karabudak R; Kurne A; Guc D; Sengelen M; Canpinar H; Kansu E
    J Neurol; 2004 Mar; 251(3):279-83. PubMed ID: 15015006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients.
    Galboiz Y; Shapiro S; Lahat N; Rawashdeh H; Miller A
    Ann Neurol; 2001 Oct; 50(4):443-51. PubMed ID: 11601495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metalloproteinases and their tissue inhibitors in multiple sclerosis.
    Ozenci V; Rinaldi L; Teleshova N; Matusevicius D; Kivisäkk P; Kouwenhoven M; Link H
    J Autoimmun; 1999 Jun; 12(4):297-303. PubMed ID: 10330301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.
    Kouwenhoven M; Ozenci V; Gomes A; Yarilin D; Giedraitis V; Press R; Link H
    J Autoimmun; 2001 Jun; 16(4):463-70. PubMed ID: 11437495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
    Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
    J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.
    Yushchenko M; Mäder M; Elitok E; Bitsch A; Dressel A; Tumani H; Bogumil T; Kitze B; Poser S; Weber F
    J Neurol; 2003 Oct; 250(10):1224-8. PubMed ID: 14586607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK
    J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.
    Bar-Or A; Nuttall RK; Duddy M; Alter A; Kim HJ; Ifergan I; Pennington CJ; Bourgoin P; Edwards DR; Yong VW
    Brain; 2003 Dec; 126(Pt 12):2738-49. PubMed ID: 14506071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
    Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
    J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of metalloproteinases and their tissue inhibitors in gingiva affected by hereditary gingival fibromatosis: analysis of three cases within a family.
    Gonçalves Lda R; Oliveira GA; Borojevic R; Otazu IB; Feres-Filho EJ
    J Periodontal Res; 2009 Dec; 44(6):714-7. PubMed ID: 19453853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
    J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
    Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
    Wilton E; Bland M; Thompson M; Jahangiri M
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Involvement of matrix metalloproteinase-2, -9, and tissue inhibitors of metalloproteinase-1, 2 in occurrence of the accrete placenta].
    Ke Y; Lu JH; Yang BL; Guo HQ; Ma QY; Zhu H; Shu HM; Li DJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):311-4. PubMed ID: 16762185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.
    Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS
    Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.